menu
    • menu

    Company profile for Polarean

    NEW Drugs in Dev: 2
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The Company and its wholly owned subsidiary, Polarean, Inc. (together the “Group”) are revenue-generating, medical imaging technology companies operating in the high-resolution medical imaging space. By researching, developing, and commercializing novel imaging solutions with a non-invasive and radiation-free functional imaging platform, Polarean’s vision is to help address the global unmet medical needs of more than 500...
    The Company and its wholly owned subsidiary, Polarean, Inc. (together the “Group”) are revenue-generating, medical imaging technology companies operating in the high-resolution medical imaging space. By researching, developing, and commercializing novel imaging solutions with a non-invasive and radiation-free functional imaging platform, Polarean’s vision is to help address the global unmet medical needs of more than 500 million patients worldwide suffering from chronic respiratory disease. Polarean is a leader in the field of hyperpolarization science and has successfully developed the first and only hyperpolarized MRI contrast agent.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PolareanUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    PO Box 14805, Research Triangle Park, NC 27709-4805
    Telephone
    Telephone
    +1 9192067900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://polarean.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/polarean-inc-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/PolareanImaging

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Polarean Expands Xenon MRI For Cardiopulmonary Drug Development
    Polarean Expands Xenon MRI For Cardiopulmonary Drug Development

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221750/0/en/Polarean-Expands-Xenon-MRI-Platform-into-Cardiopulmonary-Drug-Development-with-Multi-Center-PH-ILD-Study.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share
    CHEST Study: Xenon MRI Predicts Cystic Fibrosis Exacerbations
    CHEST Study: Xenon MRI Predicts Cystic Fibrosis Exacerbations

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216892/0/en/Polarean-Highlights-New-CHEST-Journal-Study-Demonstrating-Xenon-MRI-Predicts-Cystic-Fibrosis-Exacerbations.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    XENOVIEW 3T Coil Passes Philips Compatibility Testing
    XENOVIEW 3T Coil Passes Philips Compatibility Testing

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3197106/0/en/XENOVIEW-3T-coil-passes-Philips-compatibility-testing.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Korean Distributor Agreement with DK Healthcare in South Korea
    Korean Distributor Agreement with DK Healthcare in South Korea

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193584/0/en/Korean-distributor-agreement-with-DK-Healthcare-in-South-Korea.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Polarean & SimonMed Announce Collab to Lung Imaging Innovation
    Polarean & SimonMed Announce Collab to Lung Imaging Innovation

    28 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/28/3016375/0/en/Polarean-and-SimonMed-Announce-Collaboration-to-Advance-Lung-Imaging-Innovation.html

    GLOBENEWSWIRE
    28 Jan 2025
    Share Share
    FDA clears XENOVIEW® 3T Chest Coil in GE HealthCare MRI Systems
    FDA clears XENOVIEW® 3T Chest Coil in GE HealthCare MRI Systems

    21 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/21/2985202/0/en/FDA-clears-XENOVIEW-3T-Chest-Coil-in-GE-HealthCare-MRI-Systems.html

    GLOBENEWSWIRE
    21 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search